Distinct clinical outcomes of two CIMP-positive colorectal cancer subtypes based on a revised CIMP classification system
Downregulation of acetyl-CoA synthetase 2 is a metabolic hallmark of tumor progression and aggressiveness in colorectal carcinoma
Clinicopathologic, molecular, and prognostic implications of the loss of EPCAM expression in colorectal carcinoma
Distinct features between MLH1-methylated and unmethylated colorectal carcinomas with the CpG island methylator phenotype: implications in the serrated neoplasia pathway
Are clinicopathological features of colorectal cancers with methylation in half of CpG island methylator phenotype panel markers different from those of CpG island methylator phenotype-high colorectal cancers?
